Stratedigm Announces the Commercial Launch of the SE500 Model Flow Cytometer

Stratedigm, Inc. today announced commercial launch of its SE500 analyzer, a new cytometer designed for use in routine but demanding applications. The SE500 was launched at ISAC after completing over six months of beta testing at university test labs which have been waiting for an affordable fixed configuration system that offers the same world-class performance as Stratedigm’s S1000 platform. Based on the same technology, design and high-end components used in the S1000 analyzer, the SE500 delivers the same performance at a fraction of the price and with a fixed configuration of a blue and red laser, four colors, side scatter, forward scatter, time, and width parameters. “The launch of the SE500 system was in response to customer requests for a high performance, fixed configuration system that could be used for analyzing, dim signals, microparticles and other routine, but demanding applications,” noted Shervin Javadi, Stratedigm’s CEO.